MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · IEX Real-Time Price · USD
3.920
+0.060 (1.55%)
At close: Mar 27, 2024, 4:00 PM
3.800
-0.120 (-3.06%)
After-hours: Mar 27, 2024, 6:34 PM EDT

MEI Pharma Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Year 2023202220212020201920182017201620152014 2013 - 2002
Net Income
-31.84-54.45-41.31-47.17-16.82-40.072.67-20.86-32.69-27.15
Upgrade
Depreciation & Amortization
1.821.240.290.110.080.050.090.060.060.05
Upgrade
Share-Based Compensation
3.598.3510.256.86.563.222.32.724.224.75
Upgrade
Other Operating Activities
-26.05-3.88-1.1874.52-19.2515.76-1.570.220.342.9
Upgrade
Operating Cash Flow
-52.48-48.75-31.9634.26-29.42-21.043.49-17.86-28.07-19.45
Upgrade
Capital Expenditures
-0.04-0.48-0.71-0.89-0.220-0.05-0-0.02-0.05
Upgrade
Change in Investments
53.737.3725.42-105.424.54-44.33-10.039.98-10.04-35.02
Upgrade
Investing Cash Flow
53.696.8924.71-106.2924.32-44.33-10.089.97-10.06-35.07
Upgrade
Share Issuance / Repurchase
052.93.5378.511.7170.484.21043.0732.72
Upgrade
Other Financing Activities
-0.04-3.85-0.06-3.73-0.32-0.27----
Upgrade
Financing Cash Flow
-0.0449.053.4774.781.3970.214.21043.0732.72
Upgrade
Net Cash Flow
1.177.2-3.792.74-3.724.85-2.38-7.894.95-21.8
Upgrade
Free Cash Flow
-52.52-49.23-32.6733.36-29.64-21.043.44-17.86-28.08-19.5
Upgrade
Free Cash Flow Margin
-107.59%-120.95%-93.90%120.20%-603.05%-1296.86%14.77%---
Upgrade
Free Cash Flow Per Share
-7.88-7.91-5.817.33-8.33-10.151.87-10.38-19.91-19.44
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).